A novel mammalian cell-based approach for the discovery of anticancer drugs with reduced cytotoxicity on non-dividing cells

Author： Gonzalez-Nicolini Valeria   Fux Cornelia   Fussenegger Martin  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.22, Iss.3, 2004-08, pp. : 253-262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cell-based apoptosis assays in oncology drug discovery

By Drewe John   Cai Sui Xiong  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 6, 2010-06 ,pp. : 583-596

Informa Healthcare

Access to resources Recommend Favorite

High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening

By O’Brien P.   Irwin W.   Diaz D.   Howard-Cofield E.   Krejsa C.   Slaughter M.   Gao B.   Kaludercic N.   Angeline A.   Bernardi P.   Brain P.   Hougham C.  

Archives of Toxicology, Vol. 80, Iss. 9, 2006-09 ,pp. : 580-604

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacological Modulation of Cytotoxicity and Cellular Uptake of Anti-cancer Drugs by PDE5 Inhibitors in Lung Cancer Cells

By Li Qing   Shu Yan  

Pharmaceutical Research, Vol. 31, Iss. 1, 2014-01 ,pp. : 86-96

Springer Publishing Company

Access to resources Recommend Favorite

Adult neurogenesis and neural stem cells as a model for the discovery and development of novel drugs

By Taupin Philippe  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 10, 2010-10 ,pp. : 921-925

Informa Healthcare

Access to resources Recommend Favorite

Identification of Sanguinarine as a Novel HIV Protease Inhibitor from High-Throughput Screening of 2,000 Drugs and Natural Products with a Cell-Based Assay

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 5, 2005-08 ,pp. : 364-371

Bentham Science Publishers

Access to resources Recommend Favorite